teniposide
Facts
12 properties- Instance of
- type of chemical entity
- Has use
- medication
- Canonical SMILES
- COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O
- Chemical formula
- C₃₂H₃₂O₁₃S
- Inhibitor of
- Topoisomerase (DNA) II alpha
- Isomeric SMILES
- COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O
- Mass
- 656.156 Da
- Medical condition treated
- lung oat cell carcinoma, lung benign neoplasm, lymphoblastic leukemia, acute lymphocytic leukemia (1992–present)
- Pregnancy category
- Australian pregnancy category D, US pregnancy category D
- Route of administration
- intravenous infusion and defusionههبهلخل
- Subject has role
- topoisomerase inhibitor, antineoplastic, topoisomerase II inhibitor, developmental toxicant (1996–present)
- OpenAlex ID
- C2778707968
- ATC code
- L01CB02
- CA PROP 65 ID
- teniposide
- CAS Registry Number
- 29767-20-2
- ChEBI ID
- 75988
- ChEMBL ID
- CHEMBL452231
- ChemSpider ID
- 398606
- DSSTOX compound identifier
- DTXCID603638
- DSSTox substance ID
- DTXSID8023638
- DeCS ID
- 14091
- DrugBank ID
- DB00444
- DrugCentral ID
- 2590
Show all 40 identifiers +28
- EC number
- 249-831-2
- ECHA Substance Infocard ID
- 100.045.286
- Freebase ID
- /m/0887vh
- Guide to Pharmacology Ligand ID
- 6843
- HSDB ID
- 6546
- Human Metabolome Database ID
- HMDB0014587
- InChIKey
- NRUKOCRGYNPUPR-QBPJDGROSA-N
- KEGG ID
- D02698
- MassBank accession ID
- MSBNK-Waters-WA002621, MSBNK-Waters-WA002622, MSBNK-Waters-WA002623, MSBNK-Waters-WA002624, MSBNK-Waters-WA002625, MSBNK-Waters-WA002626, MSBNK-Waters-WA002627
- MeSH descriptor ID
- D013713
- MeSH tree code
- D09.408.348.800
- MedlinePlus drug identifier
- a692045
- Microsoft Academic ID (discontinued)
- 2778707968
- NDF-RT ID
- N0000148273
- PDB ligand ID
- 9TP
- PDB structure ID
- 4L9Q
- PatientsLikeMe treatment ID
- teniposide
- Probes And Drugs ID
- PD012680
- PubChem CID
- 452548
- RxNorm CUI
- 10362
- Römpp online ID
- RD-20-00638
- SureChEMBL ID
- 3908
- UMLS CUI
- C0039512
- UNII
- 957E6438QA
- UniChem compound ID
- 287405
- WikiProjectMed ID
- Teniposide
Subject has role 2
Has use 1
Medical condition treated 1
Route of administration 1
← Drug or therapy used for treatment 1
0 sources
Summary
teniposide is a type of chemical entity[1]. teniposide is a type of (8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one[2].
Key Facts
- Canonical SMILES: COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O[3]
- Chemical formula: C₃₂H₃₂O₁₃S[4]
- Has use: medication[5]
- Route of administration: intravenous infusion and defusionههبهلخل[6]
- Isomeric SMILES: COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3C@HC@@HO[C@H]6C@@HOC@HC@@HO[C@H]6C@@HO">[7]
- Mass: 656.156 dalton[8]
- Medical condition treated: lung oat cell carcinoma[9], lung benign neoplasm[10], lymphoblastic leukemia[11], acute lymphocytic leukemia[12]
- Subject has role: topoisomerase inhibitor[13], antineoplastic[14], topoisomerase II inhibitor[15], developmental toxicant[16]
- Pregnancy category: Australian pregnancy category D[17], US pregnancy category D[18]
- Inhibitor of: Topoisomerase (DNA) II alpha[19]